claim
In the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER), patients experienced the fewest cardiovascular events when achieving both a low-density lipoprotein cholesterol (LDL-C) <70 mg/dL and a high-sensitivity C-reactive protein (hs-CRP) <2 mg/L.

Authors

Sources

Referenced by nodes (3)